Animal studies have shown that vasopressin secretion is modulated by arterial baroreceptors and cardiopulmonary volume receptors. Whether this is the case also in humans is controversial, however. To determine whether vasopressin is reflexly modulated by cardiac volume receptors, we studied the effect on plasma vasopressin (venous blood, radiolmmunoassay) of reducing venous return and left ventricular end-diastolic diameter (echocardiography) by producing a 20-minute lower body negative pressure in 14 healthy subjects (aged 49.3±3.8 years, mean±SEM). The data were compared with those of 14 age-matched heart-transplant recipients, i.e., subjects with cardiac denervation. In healthy subjects, lower body negative pressure at -15 mm Hg caused a modest reduction in left ventricular end-diastolic diameter (-5±3.4%) and no change in vasopressin, whereas lower body negative pressure at -37.5 mm Hg caused a more marked reduction in left ventricular end-diastolic diameter (-12±2.5%) and a small, variable, but overall statistically significant (p<0.05) increase in vasopressin (+145±46%, p<0.01). The left ventricular end-diastolic diameter changes induced by the two lower body negative pressure stimuli were similar in heart-transplant recipients, but the vasopressin increase seen with the lower body negative pressure at -37.5 mm Hg was abolished. The marked increase in plasma renin activity and forearm vascular resistance induced by lower body negative pressure in healthy subjects was also abolished or drastically attenuated in heart-transplant recipients. The abolition of the responses was not due to a generalized hyporeactivity because, in heart-transplant recipients, vasopressin, plasma renin activity, and forearm vascular resistance increased normally when stimulated by hyperosmolarity, angiotensin converting enzyme inhibition, and cold, respectively. Thus, in humans vasopressin is modulated reflexly by cardiac volume receptors, although to a limited degree and only for large changes in central blood volume. The reflex influence of cardiac receptors extends to plasma renin activity and vascular resistance, indicating a role of these receptors in both blood volume and blood pressure control. antidiuretic hormone (ADH) vasopressin is modulated not only by changes in plasma osmolality but also by changes in blood volume. '-6 They have also shown that changes in blood volume act by altering the inhibitory influences of arterial baroreceptors on ADH secretion through alterations in blood pressure.
S
tudies in animals have shown that secretion of the antidiuretic hormone (ADH) vasopressin is modulated not only by changes in plasma osmolality but also by changes in blood volume.'- 6 They have also shown that changes in blood volume act by altering the inhibitory influences of arterial baroreceptors on ADH secretion through alterations in blood pressure. 3 " 5 They act even more effectively, however, by altering a similar inhibitory influence originating from cardiopulmonary receptors through alterations of the intrathoracic blood content. 6 -8 Whether cardiopulmonary receptors and baroreceptors are involved in modulation of ADH secretion in humans is controversial because alterations in central blood volume in normal and fluid-depleted individuals have produced conflicting results. 9 - 13 Recently, however, Thames and his group (Mohanty et al 14 ) have shown that the increase in vascular resistance and plasma norepinephrine induced by reducing venous return through lower body negative pressure is markedly impaired in cardiac-transplant patients and thus these responses originate from cardiac receptors. We thought that this approach could also be useful in investigating the cardiac origin of the reflex modulation of ADH. We extended the investigation to plasma renin activity (PRA) to determine the possible cardiac origin of an additional factor involved in blood volume control. 15 -' 8 Methods Our study was performed in 28 subjects of both sexes (21 men, seven women) whose age ranged from 29 to 62 years. Fourteen subjects (aged 49.3±3.8 years, mean±SEM) were healthy volunteers. The remaining 14 subjects (aged 49.7±2.3 years) had undergone a heart transplant 6±1 months before (range, 3-19 months). As shown in Table 1 , all heart-transplant recipients were Time s.t., time since cardiac transplantation; C, cyclosporine; furosemide; N, nifedipine, D, deltacortene.
*Drug therapy withdrawn 10 days before the study.
P, prednisone; A, azathioprine; L, labetalol; F, treated with azathioprine, prednisone, and cyclosporine. Four were also receiving antihypertensive drug therapy, which was withdrawn 10 days before the study. At the time of the study none of the subjects had renal insufficiency or symptoms or signs of congestive heart failure. Results of the electrocardiograms were normal; all subjects were in sinus rhythm and showed no transplant rejection at endomyocardial biopsies obtained 7.8±2.7 days before (n=9) or 9.6±6.6 days after (n=5) the study. Heart rate was typically devoid of short-term variations, indicating lack of cardiac reinnervation.
19
' 20 The hemodynamic and angiographic data obtained during the cardiac catheterization closest to the study were within the normal range (data not shown).
All subjects consented to the study after being informed of its nature and purpose. The protocol of the study was approved by the ethical committees of the two institutions involved.
Hemodynamic Measurements
In all subjects hemodynamic measurements consisted of arterial blood pressure, heart rate, forearm blood flow, and forearm vascular resistance. Arterial blood pressure was measured by a digital photoplethysmographic device capable of providing accurate beat-tobeat systolic and diastolic values. 21 ' 22 Heart rate was measured by a cardiotachometer triggered by the R wave of an electrocardiographic lead. Forearm blood flow was measured by venous occlusion plethysmography (model Ec4, Hokanson, Issaquah, Wash.) 23 using a mercury-in-Sylastic strain gauge applied around the forearm contralateral to the arm used for blood pressure measurement. The strain gauge was placed 4-5 cm below the antecubital crease, and the measurements were made at constant room temperature (23°-24°C) while circulation to the hand was arrested by application of a suprasystolic pressure in a cuff encircling the wrist. Forearm vascular resistance was calculated from the ratio between mean arterial pressure (diastolic blood pressure plus one-third of pulse pressure) and forearm blood flow.
Left ventricular end-diastolic diameter was measured by monodimensionaJ echocardiography, using bidimensional Doppler echocardiography to perform the measurements from the septal leading edge to the posterior leading edge. The measurements were made at the peak of the R wave of the electrocardiogram and were accompanied by measurements of septal wall thickness, left posterior wall thickness, and ejection fraction. Left ventricular mass index was calculated according to the Penn convention formula. 24 
Humoral Measurements
Humoral measurements consisted of plasma norepinephrine, PRA, and plasma ADH. All measurements were obtained from blood samples withdrawn from a catheter placed in an antecubital vein of the arm from which blood pressure was measured. For norepinephrine measurements, the blood samples (5 mL) were added with EGTA glutathione, put in ice-chilled tubes, centrifuged at 4°C, and kept at -70°C until assayed by the high performance liquid chromatography technique. 25 For PRA measurements, the blood samples (5 mL) were added with Na-EDTA, put in tubes maintained at room temperature, centrifuged at 4°C, and stored at -70°C until assayed by radioimmunoassay. 26 For ADH measurements, the blood samples (7 mL) were added with Na-EDTA, put in ice-chilled tubes, centrifuged at 4°C, and stored at -40°C.
Plasma ADH levels were measured by radioimmunoassay after extraction of the peptide from plasma by cation exchange chromatography by using a procedure modified from Merkelbach et al 27 and Miller and Moses. 28 Plasma samples (0.2 mL) were adjusted to pH 4.6 by addition of 1.0 mL of 0.5 M sodium acetate buffer, pH 4.5. Each sample then was transferred onto a column made from a 1-mL disposable pipette tip plugged at the tip with glass wool. This column contained 0.5 mL of a slurry of 1 g Amberlite CG-50 resin in 10 mL water. The resin had previously been washed with 0.1N acetic acid for several hours followed by repeated washes with water. The Amberlite column containing sample was suspended in the mouth of a 12x75-mm tube using a collar made from tubing. This whole unit (column containing sample suspended in test tube) was then centrifuged at approximately 50g for 50 minutes to pull the sample through the column. The sample, which collected in the test tube, was then reapplied to the column, and the centrifuging process was repeated. The column was washed with 1 mL water followed by 1 mL 50% ethanol, centrifuging each time to pull the liquid through the column. Next, the column was suspended in a clean test tube, and ADH was eluted from the column with 2 mL 75% ethanol acidified to pH 1.5 with concentrated hydrochloric acid. The elute was dried in a Savant Speed-Vac sample concentrator. The dried extract was reconstituted in 250 JAL radioimmunoassay buffer (50 mM NaPO 4 , 0.9% NaCl, 25 mM EDTA, 0.5% bovine serum albumin, 0.1% NaN 3 , pH 7.5) and centrifuged (300g for 10 minutes) to remove any particulate matter not in solution.
The radioimmunoassay was performed essentially as described by Fernstrom et al. 29 To a sample of ADH standard in a volume of 200 JAL, 100 pL antibody (1:30,000 dilution) was added. After overnight incubation at 4°C, 100 /xL radioimmunoassay buffer containing 3,000 cpm 125 I-vasopressin (New England Nuclear Corp., Boston, Mass.) was added, and the tube was incubated for an additional 2 days. Then 100 /xL normal rabbit serum (1:50 dilution) and 100 /xL goat anti-rabbit serum (1:30 dilution) were added. After overnight incubation, the tubes were centrifuged (3,000g for 20 minutes), the supernatants aspirated, and the tubes counted in a gamma-scintillation counter.
Recovery of various amounts of ADH added to 200 fih rat plasma was virtually 100% (e.g., typical assay 95±6% mean±SD; triplicate samples spiked with 2.5,5, and 10 pg vasopressin). The sensitivity of the radioimmunoassay is approximately 0.3 pg per tube (the amount that displaces 10% of bound '^I-vasopressin). The intra-assay and interassay coefficients of variation are less than 1O%. 30 
Stimulation and Deactivation of Cardiopulmonary Receptors
Activation of cardiopulmonary receptors was obtained by increasing venous return through passive elevation of the legs and the lower part of the pelvis to 50° 3U2 Deactivation of cardiopulmonary receptors was obtained by reducing venous return through application of negative pressure to the lower body. 32 The subjects were fitted in a Plexiglas box sealed at the level of anterosuperior iliac crests, and the pressure within the box was reduced below the atmospheric pressure by a commercial vacuum cleaner. The pressure reduction was set at -15 mm Hg to only moderately affect venous return, 32 leave arterial blood pressure unchanged, and thus selectively affect cardiopulmonary receptor activity and at -37.5 mm Hg to cause a reduction in blood pressure and thus deacti-vate not only cardiopulmonary receptors but arterial baroreceptors as well. 3233 Each maneuver was maintained for 20 minutes to allow development of the slower humoral responses. 1634 Increases and reductions in cardiopulmonary receptor activity were quantified by changes in echocardiographically determined left ventricular end-diastolic diameter. Because of the displacement of the heart toward the diaphragm, reliable echograms during leg raising or lower body negative pressure were obtained only in 10 control subjects and six heart-transplanted patients.
Other Tests
Blood pressure, heart rate, and forearm vascular responses to a cold pressor test were evaluated by immersion of one hand in ice water (4°C) for 60 seconds. In addition, PRA was measured before and 1 hour after intravenous injection of 40 mg furosemide and oral administration of 25 mg captopril (Capoten, Bristol Myers Squibb, Lasix, Hoeckst). This was done to assess the hemodynamic and PRA responsiveness to neural or direct stimuli different from those elicited by leg raising and lower body negative pressure. 18 -35 Plasma ADH was measured in patients before and 5 minutes after intravenous injection of a hyperosmolar solution (100 mmol NaCl in 50 mL saline). Also, this maneuver was used to assess the ADH responsiveness to a stimulus different from that originating from leg raising and lower body negative pressure. 36 
Protocol and Data Analysis
To avoid an undue challenge to the cardiovascular system of the cardiac-transplant patients, water and salt intake was allowed ad libitum. All subjects were asked to come to the laboratory in the morning and to avoid smoking cigarettes or ingesting caffeine or caffeinecontaining beverages during the 24 hours before commencing the study. Subjects were put in a supine position and enclosed in the lower body negative pressure device. The venous catheter was inserted, and the echocardiographic, blood pressure, and blood flow measuring devices were set ready. After an interval of 20 minutes, the lower body negative pressure was applied at -1 5 mm Hg followed after a 20-minute interval by the lower body negative pressure at -37.5 mm Hg. The lower body negative pressure device was removed, and the leg raising maneuver was performed. The cold pressor test and the furosemide test were performed at 20-minute intervals. Blood pressure, heart rate, forearm blood flow, forearm vascular resistance, and left ventricular end-diastolic diameter were measured 1 minute before and at the end of each stimulus. Each blood pressure and heart rate measurement was the average of the values collected over 30 seconds. Each forearm blood flow and vascular resistance measurement was the average of five consecutive values. Each left ventricular end-diastolic diameter was the average of two consecutive values. Blood samples for plasma norepinephrine, PRA, and ADH were obtained 1 minute before and at the end of the stimuli, simultaneously with the hemodynamic measurements. The withdrawal time was approximately 30 seconds.
The hyperosmolar and captopril tests were performed during two additional mornings. The hyperosmolar test was performed with the subjects supine for 30 LVEDD, left ventricular end-diastolic diameter, LVMI, left ventricular mass index; BP, blood pressure; HR, heart rate; bpm, beats per minute; FBF, forearm blood flow; FVR, forearm vascular resistance; NE, plasma norepinephrine; PRA, plasma renin activity; ADH, plasma antidiuretic hormone. Data, shown as mean±SEM, were collected at the time of the study of the cardiopulmonary reflex.
•p<0.01.
minutes and consisted of the withdrawal of blood samples for ADH and osmolar measurements before and after the injection of the hyperosmolar solution (see above). The captopril test was performed with the subjects in the sitting position for 30 minutes and consisted of the withdrawal of blood samples for PRA measurements before and after the administration of captopril. Data from individual subjects were summed to obtain mean±SEM for the group of cardiac-transplant and control subjects. The statistical significance of the difference in the means was assessed by the two-way analysis of variance. The t test for paired and unpaired observations, the Wilcoxon test, or both were used to locate the differences between baseline and stimuli data and between control subjects and cardiac-transplant patients, respectively. A value of/?<0.05 was taken as the level of statistical significance.
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Results
Baseline Echocardiographic, Hemodynamic, and Norepinephrine Values
As shown in Table 2 , left ventricular end-diastolic diameter was not significantly different in heart-transplant and control subjects. This was the case also for left ventricular mass index and for left ventricular ejection fraction. Table 2 also shows the baseline hemodynamic and humoral values obtained at the time of the cardiopulmonary receptor reflex study. Baseline systolic blood pressure, diastolic blood pressure, and heart rate were greater in heart-transplant than in control subjects. Baseline forearm blood flow was also greater in the former than in the latter group, whereas baseline plasma norepinephrine was less in heart-transplant than in control subjects. 
FIGURE 1. Bar graphs show changes in left ventricular end-diastolic diameter (LVEDD), mean arterial pressure (MAP), heart rate (HR), forearm blood flow (FBF), forearm vascular resistance (FVR), and plasma norepinephrine (NE) induced by leg raising (LR) and lower body negative pressure (LBNP) at -15 mm
Hemodynamic and Norepinephrine Responses to Leg Raising, Lower Body Negative Pressure, and Cold Pressor Test
As shown in Figure 1 in control subjects, left ventricular end-diastolic diameter increased with leg raising and decreased with lower body negative pressure at -15 mm Hg. With either maneuver blood pressure and heart rate did not change significantly, whereas forearm vascular resistance and plasma norepinephrine showed a marked reduction and increase, respectively. In hearttransplant recipients, the changes in left ventricular end-diastolic diameter induced by leg raising and lower body negative pressure at -1 5 mm Hg were similar to those of control subjects. Leg raising and lower body negative pressure at -15 mm Hg did not cause significant alterations in heart rate in either group, whereas blood pressure underwent modest changes that were somewhat greater in heart-transplant recipients than in control individuals. In heart-transplant recipients, the changes in forearm vascular resistance and in plasma norepinephrine were either absent or extremely small, whereas the changes in the forearm and norepinephrine response of control subjects were statistically significant. Compared with lower body negative pressure at -15 mm Hg, lower body negative pressure at -37.5 mm Hg caused in control subjects a more pronounced reduction in left ventricular end-diastolic diameter, a hypotension, a tachycardia, and a more pronounced increase in forearm vascular resistance and plasma norepinephrine. The reduction in left ventricular end-diastolic diameter, the hypotension, and the tachycardia induced by this maneuver were not significantly different in heart-transplant recipients. This was the case also for the increase in plasma norepinephrine, whereas the increase in forearm vascular resistance continued to be markedly attenuated in these patients as compared with the control group (Figure 1 ). Lower body negative pressure at -15 mm Hg or at -37.5 mm Hg was never associated with nausea, vomiting, or transient marked hypotension 38 in control subjects or cardiac-transplant patients. As shown in Table 3 , the increase in blood pressure and forearm vascular resistance induced by cold pressor test was similar in control and heart-transplant subjects. Cold pressor test was accompanied by a tachycardia in control subjects that was not seen in the heart-transplant group. +24.0±7.0* MAP, mean arterial pressure; HR, heart rate; bpm, beats per minute; FVR, forearm vascular resistance. Data are shown as mean±SEM. Asterisks refer to statistical significance of changes induced by cold pressor test or of differences between control and heart-transplant subjects.
•p<0.01. 
FIGURE 2. Left panel: Bar graph shows changes in plasma renin activity (PRA) induced by leg raising (LR) and lower body negative pressure (LBNP) at -15 and -37.5 mm Hg in 14 control and 14 cardiac-transplant subjects. Right panel Bar graph shows changes in PRA induced by intravenous injection offurosemide in nine control and nine heart-transplant subjects and by administration of captopril (Ace-inhibition) in five control and five heart-transplant subjects. Large asterisks on each histogram refer to statistical significance of the changes from the baseline value. Small asterisks refer to the statistical significance of the difference between control and cardiac-transplant subjects.
Plasma Renin Activity
Baseline PRA showed large interindividual differences, and the average value was not significantly different in the control (n = 14) and cardiac-transplant (n = 14) groups ( Table 2 ). As shown in Figure 2 , left panel, and in Table 4 , PRA in control subjects was reduced by leg raising and progressively increased by lower body negative pressure at -15 mm Hg and -37.5 mm Hg. In contrast, in heart-transplant subjects neither leg raising nor lower body negative pressure at -15 mm Hg and -37.5 mm Hg caused a significant change in PRA. The difference with the effect seen in control subjects was statistically significant.
In intact subjects, PRA was moderately increased by the injection of furosemide (n=9) and more markedly increased by the administration of captopril («=5). In cardiac-transplant patients, the injection of furosemide (n=9) did not alter PRA, whereas the administration of captopril (n=5) increased PRA to a degree similar to that of control subjects (Figure 2, right panel) .
Antidiuretic Hormone
Baseline ADH also showed large interindividual differences, and the average value was not significantly different in the control (n=9) and cardiac-transplant («=9) groups (Table 3) . As shown in Figure 3 , left panel, and in Table 4 , ADH in intact subjects did not change with leg raising and lower body negative pressure at -15 mm Hg, but it increased in all subjects with lower body negative pressure at -37.5 mm Hg; in two subjects the increase was extremely large. The ADH change was statistically significant in comparison with the baseline values when all subjects were considered (p<0.02) as well as when the two subjects with the greatest ADH response were removed (/?<0.01) as possible outliers. In cardiac-transplant recipients, leg raising and lower body negative pressure at -15 mm Hg and at -37.5 mmHg had no effect on ADH. The ADH response at lower body negative pressure -37.5 mm Hg observed in intact subjects was statistically significant in comparison with the corresponding values of the cardiactransplant group when all control subjects were considered (p<0.05) as well as when the two subjects with the greatest ADH response were removed (/?<0.004).
In five control subjects and five cardiac-transplant patients, the increase in plasma osmolality was accompanied by a marked increase in plasma ADH. The magnitude of the response was similar in the two groups ( Figure 3, right panel) .
Discussion
Our results provide information on the site and mode of reflex modulation of ADH secretion, renin secretion, and systemic vascular resistance in humans. These points will be discussed separately.
Reflex Modulation of Antidiuretic Hormone
In control subjects, plasma ADH remained unchanged during the small increase and reduction in cardiac volume induced, respectively, by passive leg raising and nonhypotensive lower body negative pressure at -15 mm Hg. ADH showed, however, a striking increase when lower body negative pressure at -37.5 mm Hg caused both a marked reduction in cardiac volume and a fall in arterial pressure. This contrasted with the results of cardiac-transplant patients in whom the same three stimuli, although altering cardiac volume in a similar fashion, never had any effect on plasma ADH levels. One possible explanation is that in cardiactransplant recipients, ADH was unresponsive to stimuli. However, this can be excluded because the increase in plasma ADH induced by hyperosmolarity was no less in cardiac-transplant patients than in control subjects, indicating that immunosuppressive treatment or other pathophysiological phenomena did not specifically depress ADH responsiveness. Another possible explanation is that the ADH increase depended on deactivation of arterial baroreceptors brought about by the arterial hypotension induced by lower body negative pressure at -37.5 mm Hg and that this mechanism was impaired in cardiac-transplant recipients. However, this is also unlikely because Ellenbogen et al 39 have shown that, after heart transplantation, the arterial baroreceptor ability to control heart rate recovers from the impairment typical of congestive heart failure 40 and rapidly becomes similar to that of control subjects. Furthermore, in the present study the increase in plasma norepinephrine accompanying the greater hypotensive lower body negative pressure was similar in cardiac-transplant and control individuals, suggesting that in the former, recovery includes also the baroreceptor-sympathetic modulation. Thus, the most likely explanation is that in cardiac-transplant patients, lack of ADH response was determined by denervation of the heart. This leads us to the conclusion that in humans, cardiac receptors reflexry modulate ADH secretion. These receptors are likely to be located in the ventricles because cardiac transplantation spares an atrial patch (the venousarterial junction) with a dense afferent innervation. 41 It is likely, however, to represent a rather minor and somewhat unpredictable mechanism of ADH control because the reflex increase in ADH was variable between subjects, small in most of them, and occurred only with marked alteration in central blood volume. Our subjects, however, were not water depleted and since water depletion enhances the ADH responsiveness to blood volume changes, 13 we cannot exclude that under appropriate circumstances, cardiac receptor control of ADH is more sensitive than that observed in the present study, i.e., that reflex and osmotic mechanisms controlling ADH interact in a positive fashion. 13 ' 42 In view of the results of animal studies and a few human studies, 3 -59 -1342 - 43 we also cannot exclude that in some circumstances, the arterial baroreceptor reflex participates in this control. Lewin et al 43 observed an increase in ADH in patients with congestive heart failure due to aortic stenosis during the profound hypotension brought about by valvuloplasty despite a concomitant increase in cardiac and pulmonary pressures. One can speculate that this is due to the arterial baroreceptor reflex that might be capable of modulating ADH secretion when baroreceptor deactivation is extremely marked and, as occurs in congestive heart failure, the cardiogenic reflex is impaired.
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Reflex Modulation of Plasma Renin Activity
Studies in animals demonstrate that cardiopulmonary receptors exert an important control of renin release and that this control originates to an appreciable extent from receptors located in the ventricles. 49 - 50 In humans, however, some observations indicate that PRA is modulated by cardiopulmonary receptors; other observations suggest that the reflex modulation of PRA requires the arterial baroreceptor reflex. 13 Our study shows that the reduction and increase in PRA induced in control subjects by increasing and reducing, respectively, cardiac volume was abolished in cardiac-transplant patients and that, although a reduced PRA reactivity cannot be excluded, the abolition was not due to the loss of PRA responsiveness to secreting stimuli because, although cardiac-transplant patients did not show an increase in PRA after injection of pg • ml-1 + 2O-, furosemide, they showed a PRA response to captopril even more marked than that of the control group. Considering the arguments discussed in the previous section (i.e., recovery of the arterial baroreceptor reflex in cardiac-transplant patients and preservation of the atrial patch), this suggests that in humans, reflex control of PRA also depends on cardiac and, most probably, ventricular receptors. These receptors can thus buffer blood volume changes by modulating both the activity of the reninangiotensin-aldosterone system and the plasma ADH levels.
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The results of furosemide injection deserve a further comment. Furosemide stimulates PRA secretion through the macula densa mechanism. 18 However, data in animals show that at the low doses used in our patients, PRA secretion is increased mostly as a result of an increase in renal sympathetic activity reflexly determined by the central blood volume depletion caused by the diuretic effect. 51 This mechanism was inoperative in cardiac-transplant patients, presumably accounting for the absence of the PRA response to furosemide.
Reflex Control of Vasomotor Tone
Our data confirm previous evidence that cardiac-transplant patients show normal blood pressure and vascular responses to cold exposure but that their forearm vascular and plasma norepinephrine responses to nonhypotensive lower body negative pressure are markedly reduced. 14 They also show that this is the case for the forearm vascular and plasma norepinephrine responses to leg raising. This offers additional evidence that cardiac (and also in this instance ventricular) receptors modulate systemic vascular resistance, thereby showing that cardiac receptors are involved not only in blood volume but also in blood pressure control. It also shows that the two techniques most commonly used to study human reflex influences originating from the heart 32 are both appropriate. A final important question concerns whether the loss of cardiac receptor influences may have adverse consequences for the cardiovascular homeostasis of hearttransplant patients. This is indeed indicated by the observation that during lower body negative pressure at -15 mm Hg, i.e., during a maneuver that mainly deactivates cardiac receptors, 32 cardiac-transplant patients showed a slightly greater hypotension than control subjects. However, during the greater lower body negative pressure stimulus the more marked hypotension was similar in the two groups, suggesting that a more obvious involvement of the recovered arterial baroreceptor reflex (see above) may compensate for the loss of the cardiogenic reflex and guarantees an effective sympathetic circulatory control and homeostasis. This control is known to be exerted via a sustained modulation of the sympathetic drive to all regional circulations except that of skeletal muscle, 3233 a pattern in line with our data that lower body negative pressure at -37.5 mm Hg was associated with little change in forearm vascular resistance but a marked increase in plasma norepinephrine. This increase may also be responsible for the modest tachycardia of the cardiac-transplant patients during lower body negative pressure at -37.5 mm Hg, a phenomenon presumably triggered by the supersensitivity of the pacemaker of the transplanted heart.
